Cited by 739Advanced Causal Inference TechniquesStatistical Methods in EpidemiologyStatistical Methods in Clinical Trials

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Open access

Lund, Jennifer L., Richardson, David B., Stürmer, Til·2015·Current Epidemiology Reports

DOI 10.1007/s40471-015-0053-5PMC PMC4778958

Open this paper in CoChat — free account Open PDF

Abstract

Better understanding of biases related to selective prescribing of, and adherence to, preventive treatments has led to improvements in the design and analysis of pharmacoepidemiologic studies. One influential development has been the "active comparator, new user" study design, which seeks to emulate the design of a head-to-head randomized controlled trial. In this review, we first discuss biases that may affect pharmacoepidemiologic studies and describe their direction and magnitude in a variety of settings. We then present the historical foundations of the active comparator, new user study design and explain how this design conceptually mitigates biases leading to a paradigm shift in pharmacoepidemiology. We offer practical guidance on the implementation of the study design using administrative databases. Finally, we provide an empirical example in which the active comparator, new user study design addresses biases that have previously impeded pharmacoepidemiologic studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s40471-015-0053-5

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Constructing Inverse Probability Weights for Marginal Structural Models
Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796
Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive Men
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,772
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
A meta-analysis of the association between adherence to drug therapy and mortality
Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., & Johnson, J. A. (2006) · BMJ · doi:10.1136/bmj.38875.675486.55 · Cited by 1,353
Research Methods in Occupational Epidemiology
Checkoway, H., Pearce, N. E., & Kriebel, D. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195092424.001.0001 · Cited by 889
Standardized Mortality Ratios and the "Healthy Worker Effect": Scratching Beneath the Surface
McMichael, A. J. (1976) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-197603000-00009 · Cited by 770
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 647
The Evolving Concept of the Healthy Worker Survivor Effect
Arrighi, H. M., & Hertz‐Picciotto, I. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00009 · Cited by 553
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M., & Weiss, N. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi274 · Cited by 490
Confounding Control in Healthcare Database Research
Brookhart, M. A., Stürmer‎, T., Glynn, R. J., Rassen, J. A., & Schneeweiß, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181dbebe3 · Cited by 391
Self-citation

Show all 42 references

Sorted by citations

Items 401–500 of 737

Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation
Tang, H., Zhang, B., Lu, Y., Zhang, D., Liu, R., Lu, Y., Cotsarelis, G., Asch, D. A., & Chen, Y. (2026) · BMJ · doi:10.1136/bmj-2026-100077 · Cited by 8
A Review of Causal Inference Methods for Estimating the Effects of Exposure Change when Incident Exposure Is Unobservable
Liu, F., Duchesneau, E. D., Lund, J. L., & Jackson, J. W. (2024) · Current Epidemiology Reports · doi:10.1007/s40471-024-00343-5 · Cited by 5
Self-citation
Association of Coprescribing of Gabapentinoid and Other Psychoactive Medications With Altered Mental Status and Falls in Adults Receiving Dialysis
Hall, R. K., Morton-Oswald, S., Wilson, J. A., Nair, D., Colon-Emeric, C. S., Pendergast, J., Pieper, C. F., & Scialla, J. J. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.07.013 · Cited by 5
The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia
Wang, W., Cui, Y. J., Yu, O. H. Y., Suissa, S., & Douros, A. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70014 · Cited by 5
Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults
Butler, A. M., Nickel, K. B., Olsen, M. A. A., Sahrmann, J. M., Colvin, R., Neuner, E. A., O’Neil, C. A., Fraser, V. J., & Durkin, M. J. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae519 · Cited by 6
Post‐Marketing Safety of Ustekinumab Based on 14‐Year Follow‐Up in Danish National Patient Data
Kim, S., Jensen, A., Egeberg, A., & Stensballe, L. G. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70064 · Cited by 5
Masking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events
Bai, W., Douros, A., & Gravel, C. A. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70102 · Cited by 5
Severe Acute Respiratory Failure Associated With Trimethoprim/Sulfamethoxazole Among Adolescent and Young Adults: An Active Comparator-Restricted Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS) Database
Ahmadi, F., Chalabianloo, N., McArthur, E., Omrani, M. A., Abdullah, S. S., García‐Bournissen, F., & Muanda, F. T. (2025) · Annals of Pharmacotherapy · doi:10.1177/10600280251320690 · Cited by 5
Association Between Use of WATCHMAN Device and 1-Year Mortality Using High-Dimensional Propensity Scores to Reduce Confounding
Zhao, J. Z., Ruzieh, M., Du, F., Yi, L., Foy, A., Platt, R. W., Segal, M. S., Coulombe, J., Winterstein, A. G., & Jiao, T. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011188 · Cited by 5
Incidence of venous thromboembolism following initiation of non-steroidal anti-inflammatory drugs in U.S. women
Kinsey, T. L., Stürmer‎, T., Funk, M. J., Poole, C., Simpson, R. J., & Glynn, R. J. (2019) · Rheumatology · doi:10.1093/rheumatology/kez653 · Cited by 5
Self-citation
Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark
Thomsen, R. W., Christensen, L. B., Kahlert, J. A., Knudsen, J. S., Ustyugova, A., Sandgaard, S., Holmgaard, P., Ehlers, L. H., & Sørensen, H. T. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01323-y · Cited by 5
Association of Thiazide Diuretics With Diabetes Progression, Kidney Disease Progression, Cardiovascular Outcomes, and Death Among Patients With Diabetes Who Initiate Statins.
Afify, H., Gonzalez-Morales, U., Asmar, A., Alvarez, C., & Mansi, I. (2023) · American Journal of Cardiology · doi:10.1016/j.amjcard.2023.07.057 · Cited by 4
Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study
Spangler, L., Nielson, C. M., Brookhart, M. A., Hernandez, R. K., Stad, R. K., & Lin, T. (2023) · JBMR Plus · doi:10.1002/jbm4.10793 · Cited by 5
New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
King, J. B., Berchie, R. O., Derington, C. G., Marcum, Z. A., Scharfstein, D. O., Greene, T., Herrick, J. S., Jacobs, J. A., Zheutlin, A. R., Bress, A. P., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030311 · Cited by 7
Mental Health Conditions in Partners and Adult Children of Stroke Survivors
Skajaa, N., Farkas, D. K., Laugesen, K., Fuglsang, C. H., Henderson, V. W., Plana‐Ripoll, O., Gaist, D., & Sørensen, H. T. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.3286 · Cited by 5
A discovery and verification approach to pharmacovigilance using electronic healthcare data
Dijkstra, L., Schink, T., Linder, R., Schwaninger, M., Pigeot, I., Wright, M. N., & Foraita, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426323 · Cited by 5
Hyperkalemia and maintenance of renin–angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors
Bosi, A., Xu, Y., Faucon, A., Huang, T., Evans, M., Shin, J., Fu, E. L., & Carrero, J. J. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae227 · Cited by 5
Assessing the Risk for Falls in Older Adults After Initiating Gabapentin Versus Duloxetine
Chaitoff, A., Desai, R. J., Choudhry, N. K., Jungo, K. T., Haff, N., & Lauffenburger, J. C. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-00636 · Cited by 6
Risk of adverse outcomes associated with mirtazapine compared to sertraline use among older people living in long-term care facilities
Hughes, G. A., Inacio, M. C. S., Rowett, D. S., Caughey, G. E., Air, T., Lang, C. E., Corlis, M. E., & Sluggett, J. K. (2025) · Age and Ageing · doi:10.1093/ageing/afaf074 · Cited by 6
Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort Study
Titus, J., Katukuri, V. K., Boktor, M., & Mansi, I. A. (2025) · Drug Safety · doi:10.1007/s40264-025-01558-1 · Cited by 5
Desloratadine Exposure and Incidence of Seizure: A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015
Ersbøll, A. K., Sengupta, K., Pukkala, ., Bolin, K., Aas, E., Emneus, M., Ramey, D. R., Brady, J. E., Mines, D. I., Aasbjerg, K., et al. (2021) · Drug Safety · doi:10.1007/s40264-021-01106-7 · Cited by 5
Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi‐database cohort study
Douros, A., Basedow, F., Cui, Y. J., Walker, J., Enders, D., & Tagalakis, V. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12643 · Cited by 5
Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort study
Khosrow‐Khavar, F., Azoulay, L., Montastruc, J., Montastruc, F., & Renoux, C. (2022) · Cancer · doi:10.1002/cncr.34208 · Cited by 5
Estimates of Chronic Kidney Diseases Associated with Proton-Pump Inhibitors Using a Retrospective Hospital-Based Cohort in Thailand
Pannoi, T., Promchai, C., Apiromruck, P., Wongpraphairot, S., Yang, C., & Pan, W. (2022) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s389238 · Cited by 4
Overcoming time-varying confounding in self-controlled case series with active comparators: application and recommendations
Schultze, A., Brown, J. P., Logie, J. W., Cunnington, M. C., Requena, G., Gillespie, I. A., Evans, S. J. W., Douglas, I., & Galwey, N. W. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae216 · Cited by 5
Apixaban or rivaroxaban in the treatment of acute venous thromboembolism?
Hellfritzsch, M., Grove, E. L., & Adelborg, K. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.03 · Cited by 5
Glycolysis-enhancing α1-adrenergic antagonists are neuroprotective in Alzheimer’s diseasePreprint
Zhang, Q., Schultz, J. L., Simmering, J. E., Kirkpatrick, B. Q., Weber, M. A., Skuodas, S., Hicks, T. P., Pierce, G., Laughlin, M. H., Bertolli, A. X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.03.647018 · Cited by 5
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System
Jourdain, H., Hoisnard, L., Sbidian, É., & Zureik, M. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-024-00873-4 · Cited by 4
Initiation of SGLT2 inhibitors versus mineralocorticoid receptor antagonists as third-line therapy in heart failure with reduced ejection fraction: a nationwide cohort study
Svanström, H., Mkoma, G., Hviid, A., & Pasternak, B. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101510 · Cited by 3
Active Comparator New User Cohort Studies and Matching
Stürmer‎, T., & Wang, T. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.5792 · Cited by 4
Self-citation
Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New‐User Active Comparator Cohort Study
Inoue, R., Yamaguchi, S., Okada, A., Yamauchi, T., Kadowaki, T., & Nangaku, M. (2025) · Nephrology · doi:10.1111/nep.70149 · Cited by 4
Association between denosumab use and risk of osteoarthritis among adults with osteoporosis in a real-world cohort
Zhu, Z., Huang, J.-Y., Wang, W., Liu, S., Zhang, H., Wang, Q., Fu, K., Ding, C., Wei, J. C., & Hunter, D. J. (2026) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2026.01.001 · Cited by 4
Statin Use and Reduced Risk of Pneumonia in Patients with Melioidosis: A Lung-Specific Statin Association
Coston, T. D., Wright, S. W., Phunpang, R., Dulsuk, A., Thiansukhon, E., Chaisuksant, S., Tanwisaid, K., Chuananont, S., Morakot, C., Sangsa, N., et al. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202306-552oc · Cited by 4
Association between statin use and cataract formation in a retrospective cohort study using Japanese health screening and claims data
Kawabe, K., Izumi, K., Fukasawa, N., Takashina, M., Taguchi, M., Koike, H., Sahashi, Y., & Ooba, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-97889-1 · Cited by 4
Effects of choral singing on depression and anxiety in older adults: A randomized controlled trial
Ng, T. K. S., Lim, Z. H., Todd, M. W., Sun, F., Ray, K. D., Qi, X., Guo, J., Ye, K. X., Maier, A. B., Mahendran, R., et al. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.05.061 · Cited by 4
Association between anticholinergic drug use and hepatic encephalopathy risk among patients with cirrhosis
Shih, H.-N., Wu, C., Lee, Y., & Chang, C.-C. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.06.038 · Cited by 4
Association of Glucagon-Like Peptide-1 Receptor Agonist with Incident Atrial Fibrillation
Khalil, S., Hicks, W., Burke, F. W., & Mansi, I. A. (2025) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-025-00751-y · Cited by 4
Impact of SGLT2 inhibitors on the risk of age‐related ocular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
Lee, Y., Wu, J., Chang, T., & Hung, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70131 · Cited by 4
Glucagon-Like Peptide-1 Receptor Agonists and Dementia Risk Reduction in Older Adults With Type 2 Diabetes: A Retrospective Cohort Study
Wu, J., Lin, Y., Hsu, W., Liu, T., Tsai, Y., Huang, P., Chuang, M., Yu, T., & Lai, C.-C. (2025) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2025.105901 · Cited by 5
Carfilzomib’s Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records
Jang, H. Y., Lee, H. K., Kim, C. J., Yoon, S., Kim, I., & Oh, J. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192013560 · Cited by 4
Hypoglycemia risk with inappropriate dosing of glucose-lowering drugs in patients with chronic kidney disease: a retrospective cohort study
Li, Y.-J., Chang, Y., Chou, Y., & Hsu, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-33542-z · Cited by 4
Controlling for Differential Regression-To-The-Mean via Propensity Scores: A Simulation Study
Latour, C. D., McGrath, L. J., Clouser, M. C., Nielson, C. M., Yu, Y., Balasubramanian, A., Breskin, A., & Brookhart, M. A. (2023) · Clinical Epidemiology · doi:10.2147/clep.s406552 · Cited by 4
Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Huang, H., Chen, J., Chi, N., & Chen, Y.-C. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64502 · Cited by 4
Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study
Patel, C. A., Emont, S. L., Cao, Z., Tyagi, M., & Benson, C. J. (2023) · Drugs - Real World Outcomes · doi:10.1007/s40801-023-00408-9 · Cited by 5
Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases
Tan, E. H., Rathod‐Mistry, T., Strauss, V. Y., O’Kelly, J., Giorgianni, F., Baxter, R., Brunetti, V. C., Pedersen, A. B., Ehrenstein, V., & Prieto‐Alhambra, D. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae059 · Cited by 5
A step-by-step guide to causal study design using real-world data
Hoffman, S. R., Gangan, N., Chen, X., Smith, J. L., Tave, A. K., Yang, Y., Crowe, C. L., dosReis, S., & Grabner, M. (2024) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-024-00333-6 · Cited by 4
Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
Su, Y., Shen, C., Shao, S., Lai, C., Hsu, S., Lee, C., Liu, C.-J., Hung, J., & Lai, E. C. (2024) · Age and Ageing · doi:10.1093/ageing/afae155 · Cited by 4
Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins
Chen, C., Miano, T. A., Brensinger, C. M., Leonard, C. E., Bilker, W. B., & Hennessy, S. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3479 · Cited by 4
Comparative ranking of marginal confounding impact of natural language processing-derived versus structured features in pharmacoepidemiology
Plasek, J. M., Wyss, R., Weberpals, J. G., Yang, J., DeRamus, T. P., Tsacogianis, T., Ngan, K., Bessette, L. G., Lin, K. J., & Zhou, L. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109855 · Cited by 4
Demonstrating that Real World Evidence Is Fit-For-Purpose to Support Labeling: Parallels to Patient Reported Outcomes in the Pursuit of Labeling Claims
Girman, C. J., Ritchey, M. E., McNeill, A. M., Sundell, K. A., & Meyer, R. J. (2021) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-020-00252-x · Cited by 4
A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies
Kuramoto, L., Sobolev, B. G., Rösner, J., Brasher, P. M. A., Azoulay, L., & Cragg, J. J. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5372 · Cited by 4
Arzneimittelepidemiologie und Arzneimittelverbrauchsforschung auf der Basis von Krankenkassendaten: zentrale Untersuchungsfragen und methodische Hinweise
Schübert, I. (2022) · Prävention und Gesundheitsförderung · doi:10.1007/s11553-022-00968-8 · Cited by 4
The association between prescription drugs and colorectal cancer prognosis: a nationwide cohort study using a medication-wide association study
Woo, H., Jeong, S., & Shin, A. (2023) · BMC Cancer · doi:10.1186/s12885-023-11105-9 · Cited by 4
Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients
Rastoder, E., Sivapalan, P., Eklöf, J. V., Alispahic, I. A., Jordan, A. S., Laursen, C. B., Vestbo, J., Jenkins, C. R., Nielsen, R., Bakke, P. S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11071974 · Cited by 4
Design Diagram：A Framework for Visualizing Study Designs Using Real-world Data and Improving Study Reproducibility
Fukasawa, T., Iwagami, M., Hara, A., & Urushihara, H. (2023) · Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · doi:10.3820/jjpe.28.39 · Cited by 4
The impact of alpha-1-adrenergic receptor antagonists on the progression of Parkinson disease
Opheim, K. M., Uc, E. Y., Cantrell, M. A., & Lund, B. C. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.12.008 · Cited by 3
Clarifying the causal contrast: An empirical example applying the prevalent new user study design
Young, J. C., Webster‐Clark, M., Shmuel, S., Garry, E. M., Mavros, P., Stürmer‎, T., & Girman, C. J. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5790 · Cited by 4
Self-citation
Effectiveness and Safety of Direct Oral Anticoagulants Among Octogenarians with Venous Thromboembolism: An International Multidatabase Cohort Study
Douros, A., Basedow, F., Cui, Y. J., Dimakos, J., Walker, J., Enders, D., & Tagalakis, V. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.08.033 · Cited by 4
Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study
Almadani, O. A., Alroba, R., Alfakhri, A., Almohareb, S. N., Althunian, T. A., & Alrwisan, A. A. (2024) · Drugs - Real World Outcomes · doi:10.1007/s40801-024-00431-4 · Cited by 3
Glucagon‐like Peptide‐1 Receptor Agonists in Asthma Exacerbations: An Application of High‐Dimensional Iterative Causal Forest to Identify Subgroups
Wang, T., Wang, J. H., Kinlaw, A. C., Wyss, R., Pate, V., Gou, Z., Buse, J. B., Keet, C. A., Kosorok, M. R., & Stürmer‎, T. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70192 · Cited by 5
Self-citation
Advancing causal inference in medicine using biobank data
Kaufman, H., Rappoport, N., Gilad, A., & Linial, M. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104903 · Cited by 3
Investigating the association between incretin-based therapies and thyroid cancer incidence among US Medicare beneficiaries with diabetes
Acheampong, C. O., Buse, J. B., Klein, K. R., Kim, L. T., Evron, J. M., Kahkoska, A. R., Thompson, C. A., Wang, T., Pate, V., Leese, P., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005090 · Cited by 3
Self-citation
Evaluation of Time-related Bias With Non-user Control
Morita, H., Matsuura, K., Seya, N., & Taguri, M. (2025) · Journal of Epidemiology · doi:10.2188/jea.je20250126 · Cited by 3
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists for incident dementia: A retrospective multicohort study
Anagnostakis, F., Kokkorakis, M., Nagarajan, S., Anastasiou, G., & Mantzoros, C. S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70336 · Cited by 3
Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
Roy, P. J., Colvin, R., Nickel, K. B., Ross, R. K., Durkin, M. J., Suda, K. J., Atkinson, A., & Butler, A. M. (2025) · Addiction · doi:10.1111/add.70288 · Cited by 3
Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement
Nguyen, M.-H., Tran, T. H., & Donovan, J. C. H. (2026) · Postgraduate Medicine · doi:10.1080/00325481.2026.2633464 · Cited by 3
Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study
Engström, A., Svanström, H., Hviid, A. P., Eliasson, B., Guðbjörnsdóttir, S., Wintzell, V., Hveem, K., Jonasson, C., Melbye, M., Ueda, P., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70760 · Cited by 6
Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti–Tumor Necrosis Factor or Aminosalicylates
Bertrand, A., Amiot, A., Martin, A., Carbonnel, F., & Meyer, A. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.04.015 · Cited by 3
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study
Xiang, Y., Liu, Z., Feng, J.-K., Qin, Y., Yu, H., Cheng, Y., Chen, G., Wu, J., Huang, T., Tang, Y. C., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-338462 · Cited by 3
Risk of Neuroinflammatory Diseases Among New Recipients of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs
Casey, M., Pannu, S., Bajwa, S., Duarte‐García, A., & Putman, M. (2024) · Arthritis Care & Research · doi:10.1002/acr.25340 · Cited by 3
Herpes zoster vaccine and the risk of stroke: a population-based cohort study using linked data from the Clinical Practice Research Datalink
Richardson, K., Loke, Y. K., McDonald, H. I., Parretti, H. M., & Marra, F. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000671 · Cited by 3
Rate control or rhythm control in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention
Wang, J.-Y., Mo, R., Zhu, J., Tan, J., Wang, L., Xu, W., Wang, J., Wu, S., Lyu, S., Zhang, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35218 · Cited by 3
Designing observational studies to estimate treatment effects in geriatric oncology: A closer look at confounding and its mitigation
de Glas, N. A., Pilleron, S., Bastiaannet, E., Canouï‐Poitrine, F., Serrano, A., Culakova, E., & Lund, J. L. (2024) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2024.102159 · Cited by 3
Self-citation
Natural language processing for scalable feature engineering and ultra-high-dimensional confounding adjustment in healthcare database studies
Wyss, R., Yang, J., Schneeweiß, S., Plasek, J. M., Zhou, L., DeRamus, T. P., Weberpals, J. G., Ngan, K., Tsacogianis, T., & Lin, K. J. (2025) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2025.104882 · Cited by 3
Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes and Chronic Weight Management: A Real‐World Data Study
Hurwitz, S. R., Lanes, S., Quimbo, T., Papazian, A., White, J., Fisher, V. L., Cziraky, M. J., Crowley, M. J., & Willey, V. J. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70214 · Cited by 6
Observational Studies
Donzelli, S., Loss, K. L., Zaina, F., & Négrini, S. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001824 · Cited by 3
Real-World Trends in the Evaluation of Medical Products
Hennessy, S., & Berlin, J. A. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac172 · Cited by 3
Associations of prenatal exposure to non‐steroidal anti‐inflammatory drugs with preterm birth and small for gestational age infants among women with autoimmune disorders
Delker, E., Kelly, A., Chambers, C., Johnson, D., & Bandoli, G. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5570 · Cited by 3
Association of smoking cessation patterns and untreated smoking with glaucoma, cataract, and macular degeneration: a population-based retrospective study
Tseng, Y., Huang, S.-T., Wang, C., Wang, L., & Kuo, Y.-C. (2024) · Scientific Reports · doi:10.1038/s41598-024-65813-8 · Cited by 3
Abuse-deterrent formulations and opioid-related harms in North Carolina, 2010-2018
DiPrete, B. L., Dasgupta, N., Oh, G., Moga, D. C., Slavova, S. S., Slade, E., Delcher, C., Pence, B. W., & Ranapurwala, S. I. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae252 · Cited by 3
Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self‐Controlled Case Series Study
Szilcz, M., Wastesson, J. W., Bergman, D., Johnell, K., & Ludvigsson, J. F. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70028 · Cited by 3
Lower Cancer Incidence—Warfarin Effect or Immortal Time Bias?
Li, X., Lund, J. L., & Toh, S. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.0367 · Cited by 3
Self-citation
Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age
Khosrow‐Khavar, F., Sodhi, M., Ganjizadeh‐Zavareh, S., & Etminan, M. (2021) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-021-03137-6 · Cited by 3
Periodic benefit‐risk evaluation reports have substantial promise to guide patient care and should be made publicly available
Fralick, M., & Kesselheim, A. S. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4177 · Cited by 3
Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints
Zielinski, G. D., Teichert, M., Klok, F. A., Rosendaal, F. R., Huisman, M. V., Cannegieter, S. C., & Lijfering, W. M. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4684 · Cited by 3
Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities
Alcusky, M. J., Hume, A. L., Fisher, M., Tjia, J., Goldberg, R. J., McManus, D. D., & Lapane, K. L. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0610-y · Cited by 3
Association of lithium use with rate of out-of-hospital cardiac arrest in patients with bipolar disorder
Christensen, D. M., Mohr, G. H., Kessing, L. V., Kragholm, K. H., Polcwiartek, C., Søndergaard, K. B., Wissenberg, M., Lippert, F. K., Gerds, T. A., Torp-Pedersen, C. T., et al. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100164 · Cited by 4
Association between the prolonged use of magnesium sulfate for tocolysis and fracture risk among infants
Wen, Y.-H., Wang, I., Lin, F., Hsu, H.-Y., & Wu, C. (2021) · Medicine · doi:10.1097/md.0000000000028310 · Cited by 3
Causal Inference via Electronic Health Records in the National Clinical Cohort Collaborative: Challenges and Solutions in Long COVID ResearchPreprint
Butzin-Dozier, Z., Ji, Y., Wang, L., Anzalone, A. J., Hurwitz, E. G., Patel, R. C., van der Laan, M. J., Colford, J. M., & Hubbard, A. (2025) · medRxiv · doi:10.1101/2025.06.06.25329168 · Cited by 3
Large-scale Empirical Identification of Candidate Comparators for Pharmacoepidemiological Studies
Bohn, J. M., Gilbert, J. P., Knoll, C., Kern, D. M., & Ryan, P. B. (2025) · Drug Safety · doi:10.1007/s40264-025-01569-y · Cited by 3
Post‐authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: A multi‐country European study
Schmedt, N., Alhamdow, A., Tskhvarashvili, G., Saarelainen, L., Qiao, X., Lobier, M., & Hoti, F. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16477 · Cited by 2
Opioid Agonist Therapy Adherence Trajectories Among Commercially and Publicly Insured People Living With Hepatitis C in the United States
Psaras, C., Arah, O. A., Chew, K. W., Lee, S., Javanbakht, M., Nianogo, R. A., & Seamans, M. J. (2025) · Epidemiology · doi:10.1097/ede.0000000000001895 · Cited by 2
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan
Ko, H. Y., Au, P. C.-M., Cheng, M. C., Cheung, C., Choi, A., Hsieh, M. H., Jeong, H. E., Lai, E. C., Li, B. M., Man, K. K. C., et al. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70027 · Cited by 2
Association Between Melatonin Use and Cataract Risk: A Target Trial Emulation Retrospective Cohort Study
Hung, C., Huang, J., Hung, Y.-C., Hsu, M., & Wei, J. C. (2025) · Antioxidants · doi:10.3390/antiox14081016 · Cited by 2
Clinical outcomes and safety of Chinese herbal medicine in the treatment of hyperuricemia: A retrospective real-world study
Long, Z., Zhao, H.-Y., Yin, Y., Sun, Y., Shen, P., Lin, H., Liu, J., Zhan, S., Jiang, Z.-Q., & Sun, F. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157231 · Cited by 2
Association of potentially inappropriate medications with rehospitalisation and death within three months in older patients: a systematic review and meta-analysis
Muzzarelli, I., Neumeier, V., Gagesch, M., Rösler, W., & Burch, A. (2025) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-025-02013-y · Cited by 2
Benefits of glucagon-like peptide-1 receptor agonists versus pioglitazone for cardio-hepatic outcomes: a territory-wide target trial emulation
Li, L., Lui, D. T. W., Fong, C. H.-Y., Chow, W., Au, I. C. H., Xiong, X., Lang, B. H., Wong, C. K. H., & Lee, C. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02973-5 · Cited by 2
Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes
Wu, C., Sharma, A., Edwards, J. D., Liu, P. P., Kapral, M. K., Herrmann, N., Wu, C. F., Podolsky, S., Swardfager, W., & Shah, B. R. (2025) · Diabetologia · doi:10.1007/s00125-025-06595-0 · Cited by 3
Application of the Target Trial Emulation Framework to Studies in the Pediatric Population
Sun, J. W., Horton, D. B., Savage, T. J., Burcu, M., & Hernández–Dı́az, S. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114941 · Cited by 2
A Nationwide Danish Comparative Effectiveness Study of GLP ‐1 RA , SGLT2i and DPP ‐4i Treatment on Risk of Stroke, Myocardial Infarction and Mortality in Type 2 Diabetes
Hastrup, S., Hedegaard, J. N., Andersen, G., Osler, M., Rungby, J., & Johnsen, S. P. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70165 · Cited by 2

Authors: Lund, J. L., Richardson, D. B., & Stürmer, T.
Affiliations: University of North Carolina at Chapel Hill (US)
Corresponding author: Lund, Jennifer L.
ORCID: Lund, Jennifer L.
Richardson, David B.
Venue: Current Epidemiology Reports
Publisher: Springer Science and Business Media LLC
Published: 2015-09-30
Volume: 2
Issue: 4
Pages: 221-228
ISSN: 2196-2995 (ISSN-L)
DOI: 10.1007/s40471-015-0053-5
PMC: PMC4778958
OpenAlex: W1849521086
Cited by: 739
References: 42
Citations by year: 2026: 103 · 2025: 125 · 2024: 94 · 2023: 79 · 2022: 98 · 2021: 72 · 2020: 61 · 2019: 44 · 2018: 34 · 2017: 19 · 2016: 10
FWCI: 18.69
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Current Epidemiology Reports (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (2k12ca120780-16)
National Institute on Aging (R01AG023178)
National Cancer Institute (K12-CA120780)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK124723)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords: bias in observational studies, head-to-head comparison, administrative databases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks